Pharma Newsletter – September 11 to September 15, 2017

This week, “Pharma major, Lupin announced that it has received final approval for its Metronidazole tablets USP, 250 mg and 500 mg from the Unites States Food and Drug Administration (USFDA) to market a generic version of G.D. Searle LLC’s Flagyl , 250 mg and 500 mg.”

Sep 16, 2017 10:09 IST India Infoline News Service

Top News
 
UK drug maker Indivior files patent lawsuits against Dr Reddy’s Lab
 
Indivior Plc., the UK drug firm has filed patent lawsuits against Dr Reddy’s Laboratories, Teva and Mylan, reported a global news agency on Friday. Read more
 
Lupin receives USFDA approval for generic Flagyl tablets
 
Pharma major, Lupin announced that it has received final approval for its Metronidazole tablets USP, 250 mg and 500 mg from the Unites States Food and Drug Administration (USFDA) to market a generic version of G.D. Searle LLC’s Flagyl , 250 mg and 500 mg. Read more
 
USFDA inspecting Divi's Laboratories' Unit II, stock surges over 9%
 

The US Food and Drug Administration (USFDA) is inspecting the Unit II of Divi’s Laboratories’ Visakhapatnam facility according to a leading news daily. The inspection which started on Monday is expected to conclude in a week’s time according to the referred media report. Read more

Related Story